Timothy P Kogan, Deceased

Title: The Innovations of Timothy P. Kogan

Introduction

Timothy P. Kogan was a notable inventor whose contributions to the field of biotechnology have left a lasting impact. He was based in Sugar Land, TX (US) and was known for his innovative work in the development of compounds that inhibit integrin binding. His research has implications for the treatment and prevention of various disease states.

Latest Patents

Timothy P. Kogan held a patent for "Compounds that inhibit the binding of integrins to their receptors." This patent describes a method for inhibiting the binding of the α4β1 integrin to its receptors, such as VCAM-1 and fibronectin. The patent also covers compounds that inhibit this binding, pharmaceutically active compositions comprising such compounds, and their use in formulations for controlling or preventing diseases in which α4β1 is involved. He was credited with 1 patent.

Career Highlights

Kogan worked at Texas Biotechnology Corporation, where he focused on developing innovative solutions in biotechnology. His work contributed significantly to the understanding of integrin functions and their role in various diseases.

Collaborations

Throughout his career, Kogan collaborated with notable colleagues, including Robert V. Market and Ronald J. Biediger. These collaborations helped advance the research and development of new therapeutic approaches.

Conclusion

Timothy P. Kogan's contributions to biotechnology and his innovative patents have had a significant impact on the field. His work continues to influence research and development in the treatment of diseases related to integrin binding.